Saturday 17 October 2026 Export XERS’s income statement to Excel — free account

Xeris Biopharma Holdings, Inc.

XERS Healthcare Drug Manufacturers Specialty & Generic

Xeris Biopharma Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $291.8 million, up 43.7% from fiscal 2024. In the quarter to June 2026, revenue grew 28.7%, EPS fell 1,700.0%, free cash flow grew 8,403.1% and total debt rose 15.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

10.31 0.24 +2.38%

Follow XERS

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: 54.5×
Dividend yield: —
F-score: 8/9
Altman Z: 0.98
Beneish M: −2.58
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	7	8	8	6
ROE Full definition →		107.18%	(6.96%)	(108.59%)	118.22%
ROA Full definition →		(4.52%)	0.16%	3.39%	(4.60%)
ROIC Full definition →		4.82%	12.65%	18.32%	18.88%
Return on Tangible Assets Full definition →		(13.87%)	0.41%	8.69%	(19.07%)
Average Days of Receivables Full definition →		73.72	63.85	65.26	63.23
Free Cash Flow per Share Full definition →		0.06	0.17	0.28	0.32
Free Cash Flow Full definition →		9.98	27.93	47.52	55.67
Capital Expenditures Full definition →		(0.58)	(0.70)	(1.01)	(0.94)
Other line items
Cash ROIC Full definition →		3.22%	8.09%	13.73%	15.27%
Accounts Receivable Turnover Full definition →		5.61	6.38	6.14	6.04
Accounts Payable Turnover Full definition →		5.88	15.87	4.99	4.79
Inventory Turnover Full definition →		0.73	0.73	0.70	0.61
Average Days of Payables Full definition →		57.96	26.37	94.24	75.68
Days of Inventory on Hand Full definition →		599.12	588.82	610.05	656.01
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		11.04%	10.68%	10.23%	10.38%
Selling, General and Administrative Expense of Revenue Full definition →		65.76%	62.49%	60.82%	62.05%
Share Based Compensation of Revenue Full definition →		7.77%	7.66%	7.01%	8.38%
Interest Coverage Full definition →		0.33	0.86	1.25	1.30
Operating CF/Net income Full definition →		(0.68)	51.67	4.04	(3.30)
Depreciation/Fixed assets Full definition →		3.23	3.25	3.21	3.37
Capex/Depreciation Full definition →		(0.04)	(0.04)	(0.06)	(0.06)
Revenue per Share Full definition →		1.63	1.82	1.85	1.94
Operating CF per Share Full definition →		0.06	0.18	0.28	0.33
Capex per Share Full definition →		0.00	0.00	(0.01)	(0.01)
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly